Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G48643-50 | 50 µg | $403 |
| LS-G48643-1 | 1 mg | $2,675 |
Human CCL3 / MIP-1-Alpha Protein (Recombinant His,C-terminus) (Ala23-Ala92) - LS-G48643
Human CCL3 / MIP-1-Alpha Protein (Recombinant His,C-terminus) (Ala23-Ala92) - LS-G48643
Description:
CCL3 / MIP-1-Alpha Protein LS-G48643 is a Recombinant Human CCL3 / MIP-1-Alpha produced in Yeast Ala23-Ala92 with His,C-terminus tag(s). For Research Use Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
CCL3 / MIP-1-Alpha Protein LS-G48643 is a Recombinant Human CCL3 / MIP-1-Alpha produced in Yeast Ala23-Ala92 with His,C-terminus tag(s). For Research Use Only
Specifications
Type
Recombinant Protein
Target
CCL3 / MIP-1-Alpha
Synonyms
CCL3 | C-C motif chemokine 3 | G0S19-1 | Mip1alpha | SCYA3 | SIS-beta | Chemokine (C-C motif) ligand 3 | LD78ALPHA | MIP-1-alpha | MIP1A | PAT 464.1 | Small-inducible cytokine A3
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Applications
- Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Tag
His,C-terminus
Region
Ala23-Ala92
Predicted Molecular Weight
The recombinant human CCL3 consists of 80 amino acids and predicts a molecular mass of 9.2 kDa. It migrates as an approximately 14 kDa band in SDS-PAGE under reducing conditions.
Expression System
Yeast
Source Species
Yeast
Purification
> 95 % as determined by SDS-PAGE.
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
Lyophilized from sterile PBS, pH 7.4, with 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Reconstitution
Please refer to included instructions for detailed information.
Storage
Aliquot and store at -20°C to -80°C for one year. Avoid repeated freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About CCL3 / MIP-1-Alpha
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Popular CCL3 / MIP-1-Alpha Proteins
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/18/2024
Date Requested: 4/18/2024
